NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting

Company to participate in plenary panel on artificial intelligence in psychiatry and present two scientific posters highlighting explainable AI applications in precision psychiatry TORONTO, May 20, 2026 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with advanced AI... The post NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting appeared first on Montreal Gazette .

Original source: Montreal Gazette